Please disable your Ad Blocker to better interact with this website.

Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.
News

FBI Informant Documents Conflicts With DOJ Statements About Uranium One

Will this presidential election be the most important in American history?

Conflicting information continues to raise questions about the FBI investigation of Russian efforts to buy Uranium One.

Recently, the Department of Justice claimed the evidence collected and obtained by an informant who gathered information about illegal activities surrounding the purchase of the Russian agency purchase of Uranium One was not going to yield important clues to the U.S. government decision allowing the sale.

However, over 5,000 pages of documents collected by the FBI informant and reviewed by The Hill.com shows otherwise:

An FBI informant gathered extensive evidence during his six years undercover about a Russian plot to corner the American uranium market, ranging from corruption inside a U.S. nuclear transport company to Obama administration approvals that let Moscow buy and sell more atomic fuels, according to more than 5,000 pages of documents from the counterintelligence investigation.

The memos, reviewed by The Hill, conflict with statements made by Justice Department officials in recent days that informant William Campbell’s prior work won’t shed much light on the U.S. government’s controversial decision in 2010 to approve Russia’s purchase of the Uranium One mining company and its substantial U.S. assets.

Most important, the FBI had information showing Russia’s plan to enhance control of U.S. uranium supplies and the illegal activity individuals were engaged in before the Obama administration gave approval for the sale of Uranium One to the Russians.

The Hill.com continues:

Campbell also relayed detailed information about criminal conduct throughout 2010, including the coordinates for various money laundering drops, according to his FBI debriefing reports. The evidence Campbell gathered indicated Mikerin’s corruption scheme was being directed by and benefitting more senior officials with Rosatom and Tenex back in Russia, the records show, a claim U.S. officials would make in court years later.

“There is zero doubt we had evidence of criminal activity before the CFIUS approval and that Justice knew about it through [the natural security division],” said a source with direct knowledge of the investigation.

Yet despite the information gathered by the informant Campbell, senior DOJ officials including Attorney General Jeff Sessions and Deputy Attorney General Rod Rosenstein cast doubt on the links between the illegal activity information and the sale of Uranium One.

The Department of Justice appears to be downplaying the information the FBI had before giving the OK for Russia to buy Uranium One. The question is why?

Tom Borelli

Dr. Tom Borelli is a Newsmax TV contributor and radio commentator addressing political issues from a conservative grassroots perspective. As a columnist, he has written for The Washington Times and authored articles for Newsmax Magazine, Newsmax Insider and previously was a co-host with his wife Deneen Borelli on the SiriusXM Patriot channel. Dr. Borelli appeared on numerous television programs, including the highly ranked Fox News Channel’s “The O’Reilly Factor,” “Hannity,” “The Kelly File," and "America’s News Headquarters." He has also appeared on Fox Business Network’s “Making Money with Charles Payne” and “After the Bell” as well as TheBlaze TV’s "The Glenn Beck Program" and "Dana!" Prior to working for public policy organizations, Dr. Borelli was a managing partner with the investment advisory firm of Action Fund Management, LLC and a portfolio manager for the Free Enterprise Action Fund (FEAF) where he used shareholder activism to challenge corporations that sought to profit from the growth of government. During his 25 years with the Altria Group, Inc., he built a foundation in public policy and issues management, drawing from diverse experiences ranging from basic research to corporate affairs. Dr. Borelli served as science fellow for the U.S. House of Representatives' Committee on Science, Space, and Technology during the 100th Congress. Dr. Borelli has also published scientific papers on interferon and human leukemia.

Related Articles